Engineered immune cells may be able to tame inflammation
Immune cells that are designed to soothe inflammation could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions. …
Immune cells that are designed to soothe inflammation could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions. …
Aging specifically impairs the generation of CD8+ tissue-resident memory T cells and thus compromises antitumor immunity. …
Cancer immunotherapy-associated heart inflammation is driven by an immune response distinct from the anti-tumor response, indicating that this serious complication might be managed without stopping cancer therapy. …
A phase 2 clinical trial found that pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55 percent of patients with stage 3 cutaneous melanoma. …
A study in mice found that immune-stimulating protein fragments, called guardian peptides, are produced by the brain and spinal cord to maintain the brain’s immune balance, allowing for healthy communication with the immune system. …
Researchers have discovered a mechanism that ovarian tumors use to weaken immune cells and hinder their attack by blocking the energy supply that T cells rely on. …
New research has identified a natural immune mechanism in mice that prevents cancer metastasis. …
Study reveals new understanding of the eye’s natural defense against uveitis and inflammation. …
Findings from the international FORT-2 clinical trial indicate that a promising combination treatment that includes immunotherapy is safe and well-tolerated in patients with locally advanced or metastatic bladder cancer. …
Scientists have developed an immunotherapy that protects neurons from immune cell attack at the site of traumatic spinal cord injury. …
End of content
End of content